BCG2 Health and Spitfire’s Pfizer ‘FACTORy’ wins award

  • Advertising
  • December 8, 2011
  • Cath Winks
BCG2 Health and Spitfire’s Pfizer ‘FACTORy’ wins award

BCG2 Health's Pfizer ‘FACTORy’ programme, originally developed in New Zealand in collaboration with Spitfire, and then launched into Australia, has won a Pfizer Human Health global award for commercial excellence and innovation.

Pfizer ‘FACTORy’ is a support programme linking health care professionals and their patients. Pfizer ‘FACTORy’ helps monitor a hemophiliac patient’s condition and treatment, through an i-Phone app that records and transmits medical information through a secure online database to their health care professional. There have been expressions of interest to adapt the platform for other markets.

It’s a huge win for our New Zealand and Australian client, and great recognition for our agency efforts as well. It’s also a great example of how locally produced innovations and ideas can compete and win on a world stage,says BCG2 Health's general manager Stuart Ogden.

This is a community discussion forum. Comment is free but please respect our rules:

  1. Don’t be abusive or use sweary type words
  2. Don’t break the law: libel, slander and defamatory comments are forbidden
  3. Don’t resort to name-calling, mean-spiritedness, or slagging off
  4. Don’t pretend to be someone else.

If we find you doing these things, your comments will be edited without recourse and you may be asked to go away and reconsider your actions.
We respect the right to free speech and anonymous comments. Don’t abuse the privilege.

Next page
Results for

StopPress provides essential industry news and intelligence, updated daily. And the digital newsletter delivers the latest news to your inbox twice a week — for free!

©2009–2015 Tangible Media. All rights reserved.
Use of this site constitutes acceptance of our Privacy policy.


Contact Vernene Medcalf at +64 21 628 200 to advertise in StopPress.

View Media Kit